Balchem Corporation
BCPC
$139.26
$0.760.55%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 922.44M | 926.27M | 940.59M | 946.03M | 942.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 922.44M | 926.27M | 940.59M | 946.03M | 942.36M |
| Cost of Revenue | 620.38M | 630.57M | 653.00M | 663.92M | 661.91M |
| Gross Profit | 302.06M | 295.70M | 287.59M | 282.12M | 280.45M |
| SG&A Expenses | 130.99M | 125.94M | 128.69M | 125.06M | 120.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 766.42M | 770.66M | 794.97M | 801.38M | 794.35M |
| Operating Income | 156.02M | 155.61M | 145.62M | 144.65M | 148.01M |
| Income Before Tax | 137.26M | 129.77M | 124.38M | 125.24M | 133.75M |
| Income Tax Expenses | 28.72M | 26.47M | 24.91M | 26.09M | 28.38M |
| Earnings from Continuing Operations | 108.54 | 103.30 | 99.48 | 99.15 | 105.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 108.54M | 103.30M | 99.48M | 99.15M | 105.37M |
| EBIT | 156.02M | 155.61M | 145.62M | 144.65M | 148.01M |
| EBITDA | 210.67M | 210.09M | 200.34M | 197.88M | 199.52M |
| EPS Basic | 3.37 | 3.21 | 3.10 | 3.09 | 3.28 |
| Normalized Basic EPS | 2.60 | 2.54 | 2.44 | 2.48 | 2.64 |
| EPS Diluted | 3.35 | 3.19 | 3.07 | 3.06 | 3.25 |
| Normalized Diluted EPS | 2.58 | 2.52 | 2.42 | 2.46 | 2.62 |
| Average Basic Shares Outstanding | 128.78M | 128.70M | 128.60M | 128.49M | 128.45M |
| Average Diluted Shares Outstanding | 129.80M | 129.72M | 129.61M | 129.49M | 129.55M |
| Dividend Per Share | 0.79 | 0.71 | 0.71 | 0.71 | 0.71 |
| Payout Ratio | 21.07% | 22.15% | 23.00% | 23.07% | 19.66% |
